L’ASAQ, une avancée dans la lutte contre le paludisme

by Kiechel JR, Pecoul BMed Trop, 2007, 67:109-110.

Summary: This editorial (in French) presents ASAQ, a fixed-dose combination of artesunate and amodiaquine launched in March 2007 by Drugs for Neglected Diseases initiative (DNDi) and sanofi-aventis. The combination is aimed for treating uncomplicated falciparum malaria in malaria-endemic countries in Africa.

Click here to download the full article [PDF]